Tembo Global Balance Sheet Annual

Trade

BSE: - | NSE: TEMBO | ISIN: INE869Y01010 | Sector: Biotechnology & Drugs

0.00 - (-)Updated :

Interim Data

Annual Data

Fiscal Period	2024	2023	2022	2021
Period End Date	Mar 24	Mar 23	Mar 22	Mar 21
Cash Equivalents	0.39	0.48	0.13	2.76
Cashand Short Term Investments	0.39	0.48	0.13	2.76
Accounts Receivable- Trade Net	30.77	23.56	27.45	31.48
Total Receivables Net	52.52	24.00	27.91	38.85
Total Inventory	45.17	34.55	27.69	20.01
Other Current Assets Total	24.05	17.44	10.20	0.25
Total Current Assets	122.13	76.46	65.93	61.87
Property/ Plant/ Equipment Total- Net	29.98	24.52	19.87	17.43
Intangibles Net	0.55	0.79	0.70	0.56
Long Term Investments	8.46	5.06	3.76	-
Note Receivable- Long Term	0.97	1.02	0.49	0.43
Other Long Term Assets Total	0.91	2.02	0.79	0.46
Total Assets	162.99	109.87	91.55	80.76
Accounts Payable	37.20	13.80	17.50	17.09
Accrued Expenses	0.19	0.02	0.01	-
Current Portof LT Debt/ Capital Leases	40.25	35.36	3.91	6.73
Other Currentliabilities Total	9.43	11.75	7.07	4.32
Total Current Liabilities	87.08	60.94	41.74	41.17
Long Term Debt	9.67	6.04	22.26	15.47
Capital Lease Obligations	0.00	0.74	1.27	0.64
Total Long Term Debt	9.67	6.78	23.53	16.12
Total Debt	49.93	42.14	40.69	35.89
Minority Interest	0.04	0.04	0.04	0.07
Other Liabilities Total	0.08	2.23	1.24	-
Total Liabilities	96.87	69.99	66.54	57.36
Common Stock Total	24.81	11.10	10.05	10.05
Retained Earnings( Accumulated Deficit)	41.31	28.78	14.96	13.35
Total Equity	66.12	39.88	25.00	23.40
Total Liabilities Shareholders' Equity	162.99	109.87	91.55	80.76
Total Common Shares Outstanding	2.48	1.11	1.08	1.08
Tangible Book Valueper Share Common Eq	26.43	35.21	22.51	21.15
Notes Payable/ Short Term Debt	-	-	13.26	13.04